EKO INTERNATIONAL CORPORATION

EKO INTERNATIONAL CORPORATION

OOTC:EKNL
0.00
USD
+0.00
(-99.50%)
-0.15EPS
44.55BMarket Cap
1996 Y
1997 Y
2000 Y
TTM
Revenue per Share
- -
- -
- -
0.01
Basic EPS, GAAP
-0.08
-0.09
-0.03
-0.15
Free Cash Flow per Basic Share
-0.04
-0.09
- -
- -
Dividend per Share
- -
- -
- -
- -
Book Value per Share
-0.06
0.07
-0.09
0.03
Tangible Book Value per Share
-0.06
0.07
-0.09
0.03
Basic Weighted Avg Shares
32
32
32
32
Sales/Revenue/Turnover
- -
- -
- -
- -
Operating Margin (%)
-2,700
-2,800
- -
-1,466.67
Depreciation Expense
- -
- -
- -
- -
Net Income, GAAP
-3
-3
-1
-5
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
-2,600
-3,000
- -
-1,533.33
Working Capital
-2
2
-3
1
LT Debt
- -
- -
- -
- -
Total Equity
-2
2
-3
1
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Sep'00
ST Debt
- -
LT Borrowings
- -
LT Finance Leases
- -
Preferred Equity and Hybrid Capital
- -
Shares Outstanding
32
Market Capitalization
44,554

Working Capital

USD

•

in mil. unless spec.
Sep'00
Total Current Assets
2
Cash, Cash Equivalents & STI
1
Accounts Receivable, Net
- -
Inventories
- -
Total Current Liabilities
1
Payables & Accruals
- -
ST Debt
- -
Deferred Revenue
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-218.05%
Free Cash Flow
- -
- -
-94.38%
Net Income, GAAP
- -
- -
-73.28%
Sales/Revenue/Turnover
- -
- -
-100%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2000
- -
- -
- -
- -
- -
2001
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2000
-0.06
- -
- -
- -
-0.03
2001
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2000
- -
- -
- -
- -
- -
2001
- -
- -
- -
- -
- -

Company Description

CEO
Rocky DiBenedetto
Full Time Employees
8
Sector
Miscellaneous
Industry
Miscellaneous
Address
855 Brant Street Mississauga ON Canada L7R 2J6
IPO Date
Nov 28, 2001
Business
EKO International Corp. (EKNL) operates as a holding company focused on identifying and acquiring target businesses with growth potential. Through its joint venture interest in NeuroVasc Clinical Inc., the company promotes and distributes Frequency Rhythmic Electrical Modulation System (FREMS) equipment supplied by Lorenz Neurovasc Inc.; sets up and manages clinics to treat patients using FREMS technology for peripheral neuropathy, a condition involving nerve damage in extremities such as the lower legs and feet; and establishes training and certification centers for technicians in FREMS equipment usage. FREMS devices deliver FDA- and Health Canada-approved treatments that enhance vascularity and nerve function, primarily targeting patients with diabetic complications. Founded in 2007 as Tomorrow's Morning, Inc. and renamed EKO International Corp. in December 2007, the company is headquartered at 855 Brant Street, Burlington, Ontario, Canada L7R 2J6, with operations centered in North America. No major acquisitions, partnerships, funding rounds, or strategic shifts have been reported in the last 1-2 years, as the company maintains its focus on evaluating acquisition opportunities to add assets and cash flow.